The Clinical Translation Education Group, composed of BioCanRx, CCRM, CellCAN, Ontario Institute for Cancer Research (OICR), Ontario Institute for Regenerative Medicine (OIRM) and Stem Cell Network, hosted a one-day workshop on current trends and innovations in cell and gene therapy with an emphasis on disruptive technologies. The session introduced new tools and strategies that are shaping where the biotherapeutic field is headed. The workshop took place in Toronto on September 29, 2019.
Opening remarks were made by Craig Hasilo, Chief Scientific Officer, CellCAN. Remarks were also made by workshop sponsors Barbara Leone of GE Healthcare and Alison Brown of Medicine by Design.
For information about future CTEG training and education events, visit the Events page on ccrm.ca.